JAMALUDDIN MOLOO: Open Payments
NPI 1235101197 · AURORA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$88,607 in 67 payments from 9 companies in 2025. Trend: 2023 $35,325 · 2024 $61,696 · 2025 $88,607
Speaker / faculty: $81,769Travel & lodging: $3,729Consulting: $1,706Food & beverage: $1,403
| Company | Payments | Amount |
|---|---|---|
| HEARTFLOW, INC. | 48 | $88,069 |
| Cleerly, Inc. | 3 | $181 |
| Novo Nordisk Inc | 4 | $112 |
| Amgen Inc. | 4 | $84 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $62 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Lilly USA, LLC | 1 | $23 |
| Actelion Pharmaceuticals US, Inc. | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $16 |
Products named: FFRct, Cleerly Ischemia, Wegovy, Kerendia, EVENITY, REPATHA, ZEPBOUND, WAINUA.
Industry payments across CO — which companies pay providers there.
